| Brand Name | Pathkind Diagnostics |
|---|---|
| Industry / Business Category | Healthcare / Labs |
| Founded Year | 2016 |
| Franchise Started Year | 2017 |
| Total Franchise Outlets | 1,000 – 10,000 |
| Estimated Investment | INR 50,000 – 2 Lakh |
| Franchise Fee | INR 50,000 |
| Royalty Fee | 40% |
| Space Requirement | 200 – 250 Sq.ft |
| Staff Requirement | Small team for lab operations and customer support |
| Expected Payback Period | Less than 1 year |
Pathkind Diagnostics is a healthcare service franchise focused on delivering precision diagnostic testing. It operates in the laboratory services sector, providing accurate and timely medical diagnostics for patients. Franchisees serve a broad patient demographic while leveraging the larger Pathkind network to deliver quality lab services. The business falls under the broader healthcare diagnostics franchise category.
Franchise outlets receive samples from patients and conduct diagnostic testing using standardized procedures and equipment. Daily operations involve sample collection, testing, reporting results, and managing appointments. Revenue is generated from lab tests, health check-up packages, and specialized diagnostic services. Operational workflow emphasizes speed, accuracy, and patient communication.
| Pathology Tests | Blood tests, urine analysis, and routine diagnostics |
|---|---|
| Radiology Services | Imaging diagnostics such as X-rays and ultrasound (where applicable) |
| Preventive Health Packages | Full-body check-ups and preventive screening |
| Specialized Diagnostics | Targeted tests such as hormone, diabetes, and cardiac panels |
| Initial Investment | INR 50,000 – 2 Lakh for lab setup, registration, and basic equipment |
|---|---|
| Franchise Fee | One-time INR 50,000 for brand and operational access |
| Setup Costs | Infrastructure, diagnostic equipment, signage, and marketing launch |
| Royalty / Ongoing Fee | 40% of revenue to cover support, technology, and brand utilization |
| Space Requirement | 200 – 250 Sq.ft suitable for sample collection and testing |
|---|---|
| Location Preferences | High footfall areas, near clinics, hospitals, or residential localities |
| Equipment Needs | Diagnostic machines, sample storage, and reporting systems |
| Staffing Considerations | Lab technician, receptionist, and minimal administrative support |
| Operational Training | Instruction on lab protocols, sample management, and reporting |
|---|---|
| Setup Assistance | Guidance on lab layout, equipment installation, and launch planning |
| Marketing Support | Local promotions, digital marketing guidance, and patient acquisition strategies |
| Ongoing Guidance | Continuous operational and quality assurance support from Pathkind corporate |
| Founded | 2016 |
|---|---|
| Franchise Launch | 2017 |
| Franchise Network | 1,000 – 10,000 outlets |
| Geographic Presence | Pan-India |
| Expansion Strategy | Rapid scaling through franchise model leveraging Mankind Pharma’s backing |
Pathkind Diagnostics distinguishes itself by combining a high-volume, low-space franchise model with access to advanced diagnostic technology and Mankind Pharma’s brand credibility. Unlike typical standalone labs, Pathkind offers operational protocols, centralized technology, and marketing support, enabling franchisees to achieve fast growth and revenue stability.
Investment ranges from INR 50,000 to 2 Lakh, covering lab setup, equipment, and operational readiness for franchise launch.
Franchisees manage diagnostic centers, perform sample collection, conduct tests, report results, and ensure quality compliance. Revenue comes from patient testing and health packages.
A 200–250 Sq.ft facility suffices for lab operations, patient reception, and reporting.
The expected payback period is less than one year, supported by low setup costs and steady patient demand.
Prospective franchisees contact the franchisor for application submission, approval, training, and operational onboarding. ## 14. Similar Franchise Opportunities
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.